01-07-2021 | Pleural Effusion | Case report
Afatinib/osimertinib
Grade-3 interstitial lung diseases and rash: case report
Published in: Reactions Weekly | Issue 1/2021
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event